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2SUMMARY
This report is based on analysis of data from the Cambridge cohort study of elderly
people with dementia (Ely et al, 1995), utilising re-analyses performed by Economists
Advisory Group (EAG), on behalf of Pfizer Ltd.  The clinical data has been combined
with costing figures from a programme of work based at the PSSRU (Kavanagh et al,
1993; Schneider et al, 1993; Kavanagh et al, 1995).
The report evaluates the changing average cost of care as the cognitive level of a given
person changes.   The Cambridge study provides figures for cumulative distributions
of scores that have been used to map from MMSE to OPCS SEVINT scores.  This
facilitates the use of Kavanagh (1995) figures to establish a distribution of locations
and types of care at given levels of severity.  The proportions are combined with costs
to give an average cost.  All estimates are restricted to direct costs of health and social
care and do not reflect variations in informal care and indirect costs.
The costs show a variation, with a general upwards trend matching the upward trend
in severity.  This rate of change of severity is not uniform, with variations between
different sectors of the population, dependent on age and severity of dementia.
Annual rates of change are used as the basis for extrapolation of the data over a period
of eight years, showing longer term changes in severity for any given individual.
These long term changes have some apparently anomalous effects on the pattern and
distribution of costs.
A set of more complex models will be developed, based on the work within this
report.
3INTRODUCTION
This report is a summary of part of a programme of work aimed at reviewing and
assessing economic aspects of the impact of Alzheimer's Disease.   The area has
received much attention (see Stewart, 1996, for a review) but little of this has actually
focused on evaluating the impact of therapies.  In this exercise, basic factors of costs
and disease progression are reviewed and evaluated for an important comparator
group for any study of treatments in this area: elderly persons with dementia but not
receiving any active treatment.  This group will be used in subsequent work as the
most valid comparator group.  They are not subject to some of the biases that may be
inherent in the results obtained from evaluation of placebo treatment groups.
METHODS AND DATA
This analysis brings together data from two main sources.
1. Cambridge cohort study of frail elderly people.  This is an epidemiological study
of a local population aged over 75 years of age (Ely et al, 1995).  Data on this
population is used as a basis for estimates of progression of dementia related
cognitive impairment.  The sample of persons in the study show a series of annual
progression rates.  Data highlighting these rates has been extracted from re-
analysis of the original data, performed by EAG for Pfizer Ltd.
2. PSSRU analysis of OPCS Disability Survey.  A series of series have been
produced by the PSSRU (Kavanagh et al., 1993; Kavanagh et al., 1995; Schneider
et al., 1993) examining OPCS data sets to establish the location and type of care
received by elderly persons with dementia.  The work also estimated costs of care
for persons in each location receiving different types of care.  In this report direct
costs of formal health and social care are evaluated.  There are significant costs
associated with informal care, but these are not included in the calculations.
4The above two sets of research both utilise measures of severity of cognitive
impairment, but actually use different measures.  The Cambridge study, as developed
by EAG, uses a variety of measures including CAMDEX, Blessed and MMSE.  In
contrast, the PSSRU studies are based on the same measure as the Disability Survey
uses, the OPCS SEVINT scale.  This report required use of the Cambridge
information on illness progression in conjunction with the PSSRU estimates on costs,
therefore a method was needed to map the SEVINT scores onto MMSE figures.  This
was performed by using estimates, from both sources of cumulative incidence of
levels of severity.  These levels were mapped across between the scales to establish
the nearest equivalents between each point on the two scales.  The comparisons can be
seen in Table 1.
5Table 1 MMSE / OPCS SEVINT Scores: Mapping via Cambridge City
MMSE Score Distribution in Cambridge City OPCS SEVINT Score GB
Freq % Cum% MMSE SEVINT No of Cum % %
Score Score Items
75 2.9 2.9 -1 13.0 11 1.6 1.6
6 0.2 3.1 0
1 0.0 3.1 1 12.0 10 3.0 1.4
2 0.1 3.2 3
4 0.2 3.4 4
5 0.2 3.6 5
3 0.1 3.7 6
4 0.2 3.8 7
9 0.3 4.2 8 10.5 9 4.2 1.2
7 0.3 4.4 9
12 0.5 4.9 10
11 0.4 5.3 11 9.5 8 5.4 1.1
13 0.5 5.8 12
14 0.5 6.4 13
16 0.6 7.0 14 8.0 7 6.8 1.5
22 0.8 7.8 15
32 1.2 9.0 16 7.0 6 8.5 1.6
41 1.6 10.6 17 6.0 5 9.9 1.5
44 1.7 12.3 18 4.5 4 11.4 1.5
65 2.5 14.8 19 3.5 3 14.2 2.7
83 3.2 18.0 20 2.0 2 15.2 1.0
97 3.7 21.7 21 1.0 1 15.9 0.7
127 4.9 26.6 22
155 5.9 32.5 23
210 8.0 40.6 24
256 9.8 50.4 25
260 10.0 60.3 26 0.0 0 59.9 44.0
313 12.0 72.3 27
315 12.1 84.4 28
278 10.7 95.1 29
129 4.9 100.0 30 non 100.0 40.1
disabled
The study was thus able to use Cambridge EAG data on changes in MMSE scores to
provide equivalent positions on the spectrum of SEVINT scores used by the PSSRU
work.  All of the costs have been updated to 1996 levels, using Hospital and
Community Health Services (HCHS) and Personal Social Services (PSS) Indices
(Netten and Dennett, 1996).
6A figure has been set for the average annual costs of care for a person at each different
level of the SEVINT score.  It has been established by combining the figures for costs
of care in different locations with the figures for proportions resident in different
locations at each level of severity, as in Figure 2.  The cost is then calculated as:
Cj = ∑  PijCi
                    i = 1
where:
Pij = proportion in care location φ at severity level j;
Ci = average costs of care for a person at location i;
Cj = average costs of care for a person at severity level j.
The set of states used were:
1. Living alone in private household;
2. Living with others in private household;
3. Residential accommodation (weighted average of Local Authority residential
homes, Independent Sector residential homes, Independent Sector nursing homes
and NHS hospital).












































































































































































































































































































































































































































8The updated base costs for each care location were as below:
1. Living alone in private household £12,331.63
2. Living with others in private household £14,132.60
3. Residential accommodation £24,801.05
Note that due to changes in NHS and Social Services provision the number of NHS
hospital beds for long-stay elderly persons has declined dramatically.  It was therefore
assumed that all persons resident in residential accommodation would be located in
NHS nursing homes.
These sets of figures combined to produce estimated average costs of care at the levels
shown in Table 3.
In the main analysis these figures have been applied over an eight year time span, to
model the expected progression of a person suffering from a dementia type of illness,
such as Alzheimer’s Disease.  For subsequent modelling work, this assumption on
time span may be varied.  The results show the expected outcomes of following
patients over this period of time, as measured by SEVINT, MMSE and expected costs
of care.
The analysis follows the set of patient categories used by the EAG re-analysis of the
Cambridge study:
1. 75-79 years old, mild illness;
2. 75-79 years old, moderate illness,
3. 80-84 years old, mild illness;
4. 80-84 years old, moderate illness;
5. 85+ years old, mild illness;
6. 85+ years old, moderate illness.
9The definition of mild, moderate and severe follows that used in the Cambridge study,
i.e. it is based on Blessed classifications, with estimates of correspondence to MMSE
scores..
10




One Year One Week
0 26 13826.1 265.887
1 16805.0 323.173
2 15828.8 304.399
3.5 19 15449.4 297.104
4.5 18 15767.9 303.228
6 17 16385.5 315.106
7 16 17071.8 328.305
8 14 17859.0 343.441
9.5 11 17234.2 331.427
10.5 8 17407.4 334.758





Chart 1 Cognitive Decline MMSE Over 8 Years Straight Line Extrapolation
Chart 2 Cognitive Decline SEVINT Over 8 Years Straight Line Extrapolation
Chart 3 Annual Costs at Observation Points Over 8 Years Straight Line
Extrapolation
Chart 4 Cognitive Decline MMSE Over 8 Years Adjusted
Chart 5 Cognitive Decline MMSE Over 8 Years Adjusted 75-84 Only
Chart 6 Cognitive Decline SEVINT Over 8 Years Adjusted
Chart 7 Cognitive Decline SEVINT Adjusted Over 8 Years 75-84 Only
Chart 8 Annual Costs At Observation Points Over 8 Years Adjusted
Chart 9 Annual Costs At Observation Points Over 8 Years Adjusted: 75-84
Only
Chart 10 Annual Costs At Observation Points Over 8 Years Adjusted: 75-84
Mild
Chart11 Annual Costs Bands 75-79 Mild
Chart 12 Annual Costs Bands 80-84 Mild
Chart 13 Annual Costs At Observation Points Over 8 Years Adjusted: 75-84
Moderate
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Chart 14 Annual Costs Bands: 75-79 Moderate
Chart 15 Annual Costs Bands: 80-84 Moderate
Chart 16 Annual Costs Discounted @ 6%
Chart 17 Annual Costs Discounted @ 6% 75-84 Only
Chart 18 Annual Costs Discounted @ 6% 75-84 Mild Only
Chart 19 Annual Costs Discounted @ 6% 75-84 Moderate Only
Chart 20 NPV of Costs Over 8 Years
Chart 21 Annual Costs Inflated @ 3%
Chart 22 Annual Costs Inflated @ 3% 75-84 Only
Chart 23 Annual Costs Inflated @ 3% 75-84 Mild Only
Chart 24 Annual Costs Inflated @ 3% 75-84 Moderate Only
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Chart 1
This takes figures directly from the EAG/Cambridge data.  A mean start point is
evaluated for each group and the EAG re-analysis then provides the annualised rate of
change in MMSE score, applied over eight years.  These rates of change are shown,
for each sub-group, in Table 4 and the extrapolated MMSE scores are shown in Table
5.
Table 4 Annual Rate of Change







Table 5 MMSE Scores Over Eight Years
Years From Start
0 1 2 3 4 5 6 7 8
75/79 mild 19.71 18.81 17.91 17.01 16.11 15.21 14.31 13.41 12.51
75/79 moderate 12.88 9.96 7.04 4.12 1.2 -1.72 -4.64 -7.56 -10.48
80/84 mild 19.05 18.85 18.65 18.45 18.25 18.05 17.85 17.65 17.45
80/84 moderate 14.85 11.56 8.27 4.98 1.69 -1.6 -4.89 -8.18 -11.47
85+ mild 19.69 18.09 16.49 14.89 13.29 11.69 10.09 8.49 6.89
85+ moderate 10.6 9.81 9.02 8.23 7.44 6.65 5.86 5.07 4.28
Note that scores of less than -1 are not actually measurable by the MMSE scale, they
are just notional results.  Patients have actually reached their maximum level of




These tables and chart illustrate the same process of decline as shown through changes
in SEVINT scores.  Each point on MMSE change has been mapped to the equivalent
SEVINT score, producing the set of annual projections shown in Table 6.
Table 6 SEVINT Scores Over Eight Years
0 1 2 3 4 5 6 7 8
75/79 mild 3.5 3.5 4.5 6 7 7 8 8 8
75/79 moderate 9.5 9.5 10.5 10.5 12 13 13 13 13
80/84 mild 3.5 3.5 3.5 4.5 4.5 4.5 4.5 4.5 6
80/84 moderate 8 9.5 10.5 10.5 12 13 13 13 13
85+ mild 3.5 4.5 7 8 8 9.5 9.5 10.5 10.5




















































































































































































The previous figures for the decline of SEVINT were transformed into annual costs of
care, via the process described earlier.  Table 7 shows actual figures for costs.
The figures show the expected average annual costs at each yearly interval from the
point of the EAG analysis.  A general upwards trend is evident, but it shows a
different slope to that for changes in cognitive ability.  As the measured cognitive
ability declines, the balance of locations changes, leading to changes in costs.
However, there may be some apparent anomalies in the shifts occurring at individual
levels.  In some cases, as patients decline, they move from living alone and receiving
high levels of formal care to living with others, usually close relatives, and receiving


















































































































































































































































































































































































































The first three charts, and accompanying Tables, assume that the annual rate of change
is set at the start and remains fixed over the following eight years, depending on age
group and illness severity group.  In Charts 4-7 this process of extrapolating annual
rates is refined.  As the process of decline causes cognitive scores to pass through the
thresholds separating mild, moderate and severe, the annual rate of decline is adjusted
to match the new severity group.  This leads to a change in projected levels of
cognitive ability at successive points in time, as shown in Table 8 (MMSE scores) and
Table 9 (SEVINT scores).
Table 8 Adjusted Decline, MMSE
Years From Start
0 1 2 3 4 5 6 7 8
75/79 mild 19.71 18.81 17.91 14.99 12.07 9.15 6.23 3.31 0.39
75/79 moderate 12.88 9.96 7.04 4.12 1.2 -1.72 -4.64 -7.56 -10.48
80/84 mild 19.05 18.85 18.65 18.45 18.25 18.05 17.85 14.56 11.27
80/84 moderate 14.85 11.56 8.27 4.98 1.69 -1.6 -4.89 -8.18 -11.47
85+ mild 19.69 18.09 16.49 15.7 14.91 14.12 13.33 12.54 11.75
85+ moderate 10.6 9.81 9.02 8.23 7.44 6.65 5.86 5.07 4.28
Table 9 Adjusted Decline, SEVINT
Years From Start
0 1 2 3 4 5 6 7 8
75/79 mild 3.5 3.5 4.5 8 9.5 10.5 10.5 12 12
75/79 moderate 8 9.5 10.5 12 12 13 13 13 13
80/84 mild 3.5 3.5 3.5 4.5 4.5 4.5 4.5 8 9.5
80/84 moderate 8 9.5 10.5 10.5 12 13 13 13 13
85+ mild 3.5 4.5 7 7 8 8 8 8 9.5
85+ moderate 9.5 9.5 10.5 10.5 10.5 10.5 10.5 10.5 12
Charts 4 and 6 show this adjusted decline for the whole population, for MMSE and
SEVINT respectively.  In Charts 5 and 7 clarity is enhanced by removing those over
85 years, as there are only a small number of cases.  This allows a clearer focus on the
key age groups, 75-79 years of age and 80-84 years of age.  One point of interest
21
emerges from Chart 7.  Measured by SEVINT scores, the ‘moderate’ groups in both
categories appear to change at a fairly similar  rate.  However, the mild groups differ,
with the 80-84 age group apparently changing far less than those aged 75-79.  It is
possible that this apparent anomaly is a sampling problem, generated by the reltively












































































































































































































































































































































































This next set of charts takes the data for adjusted levels of cognitive decline and
combines this with the data on costs of care, as used in Chart 3.  The first example,
Chart 8, shows the costs at each point for each of the age and severity sub-groups,
using revised figures for cognitive decline.  Costs figures are shown in Table 10.
Chart 9 removes the 85+ age group to highlight the key groups of 75-79 years old and
80-84 years old.  Chart 10 then picks out the group rated as of mild severity.  This
shows some apparent anomalies in the progression of costs levels, as discussed earlier.
These anomalies are seen more sharply in Chart 11, which concentrates on the 75-79
age group and separates out different bands of annual costs.  That is, it shows where
the increase in severity leads to the crossing of a threshold where a different mix of
care is provided.  The annual costs show a gradual trend upwards, but with a sharp rise
in year three followed by a fall in year four, with a subsequent resumption in the
upward trend.  If one examines Table 2, showing the relative location of patients
(from Kavanagh et al, 1995) this data can be matched with the change in costs at Year
3.  This shows that the shift from SEVINT of 4.5 at Year 2 to SEVINT of 8 at Year 3
results in a shift to a more costly mix of care locations.
In Chart 12, covering the 80-84 age group, a similar general upward trend can be seen.














































































































































































































































































































































































































































































































































































































































































































































































Charts 13-15 repeat this process for the groups defined as ‘moderately ill’.  In Charts
14 and 15 the bands of annual costs are shown, illustrating how both groups show an
immediate dip in the level of expected costs.  Both age groups (75-79 and 80-84)
reach their highest point early on, by Year 5.  As they are more severely ill at the onset
of the analysis, it appears intuitive that they should reach a peak of costs faster than


































































































































































































































































































This set of charts follows the expected costs of care, as calculated previously, and
applies the principle of discounting to reflect the lower present value of future costs.
Table 11 shows the discounted values of costs in each year f the eight year period.
As shown in Chart 16, discounting of future values results in an observable reduction
in the current value of future costs.  This gives a set of figures for the present value
(PV) of the costs of eight years of care.
PVi = Ci / (1+r)i
where  PVi = Present value of costs of care in year i
Ci = Total costs of care in year i, at current price levels in year i
              r = Discount rate.
Chart 17 removes the 85+ age group to focus on the key groups, the 75-79 and 80-84













































































































































































































































































































































































































































































































































































































































































































































The previous analysis showed the discounted values of future cost in any given year.
By aggregating these figures we arrive at the net present value (NPV) of costs over the
eight year time span.  This can be expressed as:
                       N
NPV = ∑ Ci / (1 + r)i
                                   i = 1
where
                                  N = Time span, in years
                                  Ci = Costs of care in year i
                                   r = Discount rate








This shows clearly that costs will be higher for patients initially in the ‘moderate’




















































































The discounting of future costs, to produce NPV, is in line with economic theory and
with standard financial theory.  However, for service providers and planners costs of
care are paid for at current prices, irrespective of the point in time that is being
examined.  Hence, such persons may be more interested in projected costs, measured
at future levels of current prices.  Therefore, this next set of analyses takes all
projected annual costs and applies an estimate of future costs inflation.  A rate of 3%
has been used.  There are no available forecasts of HCHS or PSS for the next eight
years, therefore this figure is just hypothesis.  It is in line with recent trends (Netten
and Dennett, 1996) and provides some guidance.  If actual inflation is higher then
future costs will of course be higher, and vice versa.
As can be seen from Table 13, the value of yearly costs rises steadily, peaking in the
range of £22,000 to £26,000 per annum.  This is an approximate indication of the cash
sums that will be required at future points to provide care for those currently at given













































































































































































































































































































































































































































































































































































































































































































The general conclusions from this work are in line with intuitive expectations.  After
diagnosis of dementia there is a progressive decline in cognitive ability, as measured
by either SEVINT or MMSE.
Over an eight year period this decline leads to a gradual increase in costs of care, as
people move away from living at home towards residential care and other more costly
interventions.  There are some anomalies, so the change is not a smooth upward slope.
However, it does appear that if people were prevented from moving along the slope of
cognitive decline there would be a beneficial effect on levels of expected costs.  They
would be held down as people remain at lower points on the spectrum of cognitive
disability and impose fewer demands on providers of health and social services.
52
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